Viewing Study NCT04415567


Ignite Creation Date: 2025-12-25 @ 12:34 AM
Ignite Modification Date: 2025-12-25 @ 10:43 PM
Study NCT ID: NCT04415567
Status: COMPLETED
Last Update Posted: 2020-06-04
First Post: 2020-05-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation
Sponsor: Jinyang Gu
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular Carcinoma View
None liver transplantation View
None lenvatinib View
None adjuvant therapy View